• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 SonoVue 增强术中超声与切除的肝细胞癌组织学分级的相关性。

Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.

机构信息

Division of Hepato-Biliary-Pancreatic , Department of Surgery, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

出版信息

AJR Am J Roentgenol. 2011 Jun;196(6):1314-21. doi: 10.2214/AJR.10.4310.

DOI:10.2214/AJR.10.4310
PMID:21606294
Abstract

OBJECTIVE

Our aim was to accurately assess the correlation between findings of contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of hepatocellular carcinoma (HCC).

SUBJECTS AND METHODS

We enrolled 239 consecutive patients who were undergoing surgery for HCC for this study. Because 33 extensively necrotic HCCs were excluded, a total of 374 histologically proven HCCs were detected in all resected specimens and were the study subjects (71 well-differentiated, 239 moderately differentiated, and 64 poorly differentiated HCCs). After a laparotomy and liver mobilization, contrast-enhanced intraoperative ultrasound in the harmonic mode was performed after a Sonazoid injection. The first minute was defined as the vascular phase, in which the vascularity of the 239 HCCs was assessed. After an approximately 15-minute delay, a thorough liver exploration was performed (Kupffer phase). Preoperative dynamic CT was routinely performed, and the findings were assessed for reference.

RESULTS

The proportion of hypervascular tumors during the vascular phase tended to be lower among well-differentiated than among moderately and poorly differentiated HCCs (66% vs 80%, p = 0.058). The proportion of hypoechoic tumors during the Kupffer phase was significantly lower among well-differentiated than among moderately and poorly differentiated HCCs (54% vs 92%, p < 0.0001). In dynamic CT, the proportions of hypervascular tumors during the early phase and hypodense tumors during the late phase were significantly lower among well-differentiated HCCs than among moderately and poorly differentiated HCCs, respectively (early phase, 51% vs 87%, p < 0.0001; late phase, 59% vs 85%, p < 0.0001).

CONCLUSION

Contrast-enhanced intraoperative ultrasound using Sonazoid is useful for estimating the histologic grade of HCC.

摘要

目的

本研究旨在准确评估 SonoVue 增强术中超声与肝细胞癌(HCC)组织学分级之间的相关性。

对象和方法

本研究纳入了 239 例因 HCC 接受手术的连续患者。由于排除了 33 例广泛坏死的 HCC,因此在所有切除标本中总共检测到 374 例经组织学证实的 HCC,这些 HCC 为研究对象(71 例分化良好、239 例中分化、64 例低分化 HCC)。剖腹术和肝游离后,在 SonoVue 注射后进行谐波模式的增强术中超声。第 1 分钟定义为血管相,评估 239 例 HCC 的血管生成。大约 15 分钟后,进行彻底的肝脏探查(Kupffer 相)。常规进行术前动态 CT,评估结果以供参考。

结果

在血管相期间,高血管肿瘤的比例在分化良好的 HCC 中低于中分化和低分化 HCC(66%比 80%,p=0.058)。在 Kupffer 相中,低回声肿瘤的比例在分化良好的 HCC 中明显低于中分化和低分化 HCC(54%比 92%,p<0.0001)。在动态 CT 中,在早期相期间高血管肿瘤的比例和在晚期相期间低衰减肿瘤的比例在分化良好的 HCC 中明显低于中分化和低分化 HCC(早期相,51%比 87%,p<0.0001;晚期相,59%比 85%,p<0.0001)。

结论

SonoVue 增强术中超声对估计 HCC 的组织学分级有用。

相似文献

1
Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.使用 SonoVue 增强术中超声与切除的肝细胞癌组织学分级的相关性。
AJR Am J Roentgenol. 2011 Jun;196(6):1314-21. doi: 10.2214/AJR.10.4310.
2
Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma.钆塞酸二钠增强术中超声在肝细胞癌患者中的应用价值。
Ann Surg. 2011 Dec;254(6):992-9. doi: 10.1097/SLA.0b013e31822518be.
3
Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.对比增强超声应用全氟丁烷微泡造影剂:肝细胞癌的鉴别诊断评估。
AJR Am J Roentgenol. 2011 Feb;196(2):W123-31. doi: 10.2214/AJR.10.4242.
4
Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images.索纳昔对比增强超声检查对肝细胞癌的应用价值:与病理诊断及超顺磁性氧化铁磁共振成像的比较
J Gastroenterol. 2009;44(7):733-41. doi: 10.1007/s00535-009-0053-7. Epub 2009 Apr 23.
5
Contrast-enhanced intraoperative ultrasound for hepatocellular carcinoma: high sensitivity of diagnosis and therapeutic impact.对比增强术中超声在肝细胞癌中的应用:高诊断灵敏度和治疗影响。
J Hepatobiliary Pancreat Sci. 2013 Feb;20(2):234-42. doi: 10.1007/s00534-012-0507-9.
6
Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI.多步骤肝癌发生过程中索拉非尼增强超声成像:与钆塞酸二钠增强MRI的比较
J Gastroenterol. 2014 Jun;49(6):1081-93. doi: 10.1007/s00535-013-0859-1. Epub 2013 Aug 1.
7
Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma.新型超声技术——缺陷再灌注超声成像,应用声诺维在肝细胞癌治疗中的应用。
Oncology. 2010 Jul;78 Suppl 1:40-5. doi: 10.1159/000315229. Epub 2010 Jul 8.
8
Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity.肝细胞癌的超顺磁性氧化铁增强磁共振成像:与组织学肿瘤分级及肿瘤血管形成的相关性
J Magn Reson Imaging. 2004 Jan;19(1):76-81. doi: 10.1002/jmri.10425.
9
Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography.Sonazoid®增强超声、钆二乙烯三胺五乙酸增强磁共振成像和对比增强计算机断层扫描联合在肝细胞癌诊断中的应用价值。
Oncology. 2011;81 Suppl 1:66-72. doi: 10.1159/000333264. Epub 2011 Dec 22.
10
Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma.肿瘤血管生成的改变先于肝细胞癌去分化过程中微泡对比剂蓄积缺陷。
Eur J Radiol. 2010 Jul;75(1):e102-6. doi: 10.1016/j.ejrad.2009.08.017. Epub 2009 Sep 23.

引用本文的文献

1
Current status and future perspectives of contrast-enhanced ultrasound diagnosis of breast lesions.乳腺病变超声造影诊断的现状与展望。
J Med Ultrason (2001). 2024 Oct;51(4):611-625. doi: 10.1007/s10396-024-01486-0. Epub 2024 Aug 23.
2
Image-guided surgery and novel intraoperative devices for enhanced visualisation in general and paediatric surgery: a review.图像引导手术及新型术中设备在普通外科和小儿外科增强可视化中的应用:综述
Innov Surg Sci. 2022 Feb 2;6(4):161-172. doi: 10.1515/iss-2021-0028. eCollection 2021 Dec 1.
3
Second-line Sonazoid-enhanced ultrasonography for Liver Imaging Reporting and Data System category 3 and 4 on gadoxetate-enhanced magnetic resonance imaging.
钆塞酸二钠增强磁共振成像中肝脏影像报告和数据系统3类和4类病变的二线钆贝葡胺增强超声检查
Ultrasonography. 2022 Jul;41(3):519-529. doi: 10.14366/usg.21198. Epub 2022 Jan 28.
4
Diagnostic criteria of perfluorobutane-enhanced ultrasonography for diagnosing hepatocellular carcinoma in high-risk individuals: how is late washout determined?全氟丁烷增强超声检查诊断高危人群肝细胞癌的诊断标准:如何确定延迟洗脱?
Ultrasonography. 2022 Jul;41(3):530-542. doi: 10.14366/usg.21172. Epub 2021 Dec 17.
5
Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound.肝细胞癌的影像学诊断:特别强调肝胆磁共振成像和对比增强超声的未来方向。
Clin Mol Hepatol. 2022 Jul;28(3):362-379. doi: 10.3350/cmh.2021.0361. Epub 2021 Dec 27.
6
Emerging contrast-enhanced ultrasound applications in children.新兴的超声造影在儿科的应用。
Pediatr Radiol. 2021 Nov;51(12):2418-2424. doi: 10.1007/s00247-021-05045-4. Epub 2021 Apr 1.
7
Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease.超声技术在肝细胞癌和非酒精性脂肪性肝病评估中的表现及人工智能的潜力
Cancers (Basel). 2021 Feb 14;13(4):790. doi: 10.3390/cancers13040790.
8
Early hemodynamics of hepatocellular carcinoma using contrast-enhanced ultrasound with Sonazoid: focus on the pure arterial and early portal phases.使用声诺维增强超声对肝细胞癌进行早期血流动力学研究:聚焦于纯动脉期和早期门静脉期。
Glob Health Med. 2020 Oct 31;2(5):319-327. doi: 10.35772/ghm.2020.01092.
9
Diagnostic Value of Imaging Methods in the Histological Four Grading of Hepatocellular Carcinoma.影像学方法在肝细胞癌组织学四级分级中的诊断价值
Diagnostics (Basel). 2020 May 19;10(5):321. doi: 10.3390/diagnostics10050321.
10
Hepatocellular Carcinoma: Current Imaging Modalities for Diagnosis and Prognosis.肝细胞癌:诊断和预后的当前影像学方法。
Dig Dis Sci. 2019 Apr;64(4):934-950. doi: 10.1007/s10620-019-05547-0.